Dorinol Injection
Dorinol Injection contains Doripenem 500 mg, a broad-spectrum carbapenem antibiotic developed for the treatment of serious and life-threatening bacterial infections. It exhibits potent activity against a wide range of gram-positive, gram-negative, and anaerobic pathogens, including many resistant strains.
Doripenem works by inhibiting bacterial cell wall synthesis, leading to rapid bacterial eradication. Dorinol is particularly effective in managing complicated intra-abdominal infections, urinary tract infections, hospital-acquired pneumonia, ventilator-associated pneumonia, and septicemia, especially in critically ill patients.
The formulation is intended for intravenous administration only and is supplied as a single-dose vial, ensuring accurate dosing and reduced risk of contamination. The addition of EDTA enhances stability and helps maintain optimal antimicrobial effectiveness.
Manufactured under strict quality and safety standards, Dorinol Injection ensures high purity, stability, and consistent therapeutic performance, making it a reliable choice in hospital and intensive care settings.
Key Features:
- Doripenem for Injection 500 mg
- Broad-spectrum carbapenem antibiotic
- Effective against resistant bacterial infections
- For IV use only | Single-dose vial
- Ideal for severe and hospital-acquired infections
Dorinol Injection is a trusted solution for healthcare professionals seeking effective control of complex and critical bacterial infections.
Disclaimer:
This information is for registered medical practitioner only. Anyone other than medical practitioner should consult medical practitioner before using this product.